IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,781,000 | +304.2% | 32,710 | +68.6% | 1.42% | +263.7% |
| Q2 2020 | $688,000 | -27.5% | 19,400 | -60.7% | 0.39% | -40.5% |
| Q1 2019 | $949,000 | +33.9% | 49,377 | -0.6% | 0.66% | +6.8% |
| Q4 2018 | $709,000 | -50.8% | 49,682 | -28.1% | 0.62% | -30.8% |
| Q3 2018 | $1,440,000 | -27.6% | 69,135 | -17.7% | 0.89% | -27.4% |
| Q2 2018 | $1,989,000 | +415.3% | 84,015 | +218.2% | 1.22% | +412.6% |
| Q1 2018 | $386,000 | – | 26,400 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |